Empogagen 10 mg (Empagliflozin)

Adult dose

The recommended dosage of this medication is 10 mg once daily, whether used alone or in addition to insulin or other hypoglycemic agents. If tolerance is good and additional blood sugar control is needed, the dosage may be increased to 25 mg once daily. This drug can be taken regardless of meals, and the tablets should be swallowed whole. If a dose is missed, it should be taken as soon as remembered; do not double the next dose on the same day.

This drug should not be used in patients with allergic reactions to the active ingredient or any components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication is also contraindicated for patients with severely impaired kidney function or those on dialysis due to end-stage kidney disease. It contains lactose and should not be given to patients with lactose intolerance or related genetic disorders. In patients with reduced kidney function, this drug should be used cautiously, and dosage adjustments or discontinuation may be required based on kidney function test results. There is limited experience with this drug in some heart failure patients, so it should be used carefully and is not recommended for those with severe heart failure. When used with other medications like insulin or sulfonylureas, monitoring is necessary for the risk of hypoglycemia, with possible dose adjustments required for these medications. During treatment with this drug, precautions should be taken for potential side effects such as hypoglycemia, urinary tract infections, genital fungal infections, and reduced fluid volume. Particularly, serious metabolic disturbances such as ketoacidosis can occur, and immediate consultation with healthcare professionals is necessary upon symptom onset. Elderly patients or those at risk of fluid volume loss should be monitored closely for symptoms of hypotension or dehydration. This drug may have a mild effect on driving or operating machinery, so caution is advised in cases of high hypoglycemia risk. Pregnant or breastfeeding women are advised to avoid this medication, and treatment should be suspended upon confirmation of pregnancy. The safety and efficacy of this drug have not been established for children and adolescents under 18 years of age, hence it should not be used in this population. No specific toxic symptoms have been reported in cases of overdose, but immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to other containers.

Serious side effects

• Hives
• angioedema
• gangrene of the perineum
• ketoacidosis
• uroseptic shock
• pyelonephritis
• severe allergic reactions
• severe skin reactions
• liver abnormalities (jaundice)
• severe edema or urination abnormalities

Mild side effects

• Hypoglycemia
• genital mycotic infections
• vulvovaginitis
• balanitis and other genital infections
• increased urination
• rashes
• itching
• increased serum creatinine
• decreased glomerular filtration rate
• thirst

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.

Appearance

Pale yellow, double convex circular film-coated tablet

Package unit

30 tablets/bottle